{"count": 13, "results": [{"_id": "37750649", "pmid": 37750649, "title": "Effect of Ezetimibe combined with Simvastatin in the treatment of coronary heart disease: a retrospective analysis.", "journal": "Eur Rev Med Pharmacol Sci", "authors": ["Li B", "Li Y", "Peng WZ", "Liu YQ", "Xu ZS", "Wen JK"], "date": "2023-09-01T00:00:00Z", "doi": "10.26355/eurrev_202309_33581", "meta_date_publication": "2023 Sep", "meta_volume": "27", "meta_issue": "17", "meta_pages": "8212-8217", "score": 50263.395, "text_hl": "During the treatment, the incidence of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@MACE@@@ in the @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@Simvastatin+Ezetimibe@@@ group (3.85%) was significantly lower than that in the @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ group (16.33%) (p<0.05). ", "citations": {"NLM": "Li B, Li Y, Peng WZ, Liu YQ, Xu ZS, Wen JK. Effect of Ezetimibe combined with Simvastatin in the treatment of coronary heart disease: a retrospective analysis. Eur Rev Med Pharmacol Sci. 2023 Sep;27(17):8212-8217. PMID: 37750649", "BibTeX": "@article{37750649, title={Effect of Ezetimibe combined with Simvastatin in the treatment of coronary heart disease: a retrospective analysis.}, author={Li B and Li Y and Peng WZ and Liu YQ and Xu ZS and Wen JK}, journal={Eur Rev Med Pharmacol Sci}, volume={27}, number={17}, pages={8212-8217}}"}}, {"_id": "16351680", "pmid": 16351680, "title": "Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.", "journal": "Int J Clin Pract", "authors": ["Kastelein JJ", "Sankatsing RR"], "date": "2005-12-01T00:00:00Z", "doi": "10.1111/j.1368-5031.2005.00737.x", "meta_date_publication": "2005 Dec", "meta_volume": "59", "meta_issue": "12", "meta_pages": "1464-71", "score": 50100.734, "text_hl": "This article will review clinical experience to date with @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@ezetimibe/simvastatin@@@, commenting upon its place and potential value in the prevention of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular disease@@@.", "citations": {"NLM": "Kastelein JJ, Sankatsing RR. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia. Int J Clin Pract. 2005 Dec;59(12):1464-71. PMID: 16351680", "BibTeX": "@article{16351680, title={Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.}, author={Kastelein JJ and Sankatsing RR}, journal={Int J Clin Pract}, volume={59}, number={12}, pages={1464-71}}"}}, {"_id": "20538134", "pmid": 20538134, "title": "Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.", "journal": "Am J Cardiol", "authors": ["Holme I", "Boman K", "Brudi P", "Egstrup K", "Gohlke-Baerwolf C", "Kesäniemi YA", "Malbecq W", "Rossebø AB", "Wachtell K", "Willenheimer R", "Pedersen TR"], "date": "2010-06-15T00:00:00Z", "doi": "10.1016/j.amjcard.2010.01.363", "meta_date_publication": "2010 Jun 15", "meta_volume": "105", "meta_issue": "12", "meta_pages": "1802-8", "score": 50077.188, "text_hl": "Observed and predicted reduction of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@ischemic cardiovascular@@@ events in the @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@Simvastatin and Ezetimibe@@@ in @DISEASE_Aortic_Valve_Stenosis @DISEASE_MESH:D001024 @@@Aortic Stenosis@@@ trial.", "citations": {"NLM": "Holme I, Boman K, Brudi P, Egstrup K, Gohlke-Baerwolf C, Kesäniemi YA, Malbecq W, Rossebø AB, Wachtell K, Willenheimer R, Pedersen TR. Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial. Am J Cardiol. 2010 Jun 15;105(12):1802-8. PMID: 20538134", "BibTeX": "@article{20538134, title={Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial.}, author={Holme I and Boman K and Brudi P and Egstrup K and Gohlke-Baerwolf C and Kesäniemi YA and Malbecq W and Rossebø AB and Wachtell K and Willenheimer R and Pedersen TR}, journal={Am J Cardiol}, volume={105}, number={12}, pages={1802-8}}"}}, {"_id": "25912112", "pmid": 25912112, "title": "Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.", "journal": "Int J Cardiol", "authors": ["Chang SH", "Wu LS", "Lee CH", "Kuo CT", "Liu JR", "Wen MS", "Chen WJ", "See LC", "Yeh YH"], "date": "2015-01-01T00:00:00Z", "doi": "10.1016/j.ijcard.2015.04.121", "meta_date_publication": "2015", "meta_volume": "190", "meta_issue": "", "meta_pages": "20-5", "score": 50072.273, "text_hl": "The potential benefits of @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@simvastatin-ezetimibe@@@ for @SPECIES_9606 @@@patients@@@ at a lower risk of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@MACE@@@ are unclear. ", "citations": {"NLM": "Chang SH, Wu LS, Lee CH, Kuo CT, Liu JR, Wen MS, Chen WJ, See LC, Yeh YH. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study. Int J Cardiol. 2015;190():20-5. PMID: 25912112", "BibTeX": "@article{25912112, title={Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.}, author={Chang SH and Wu LS and Lee CH and Kuo CT and Liu JR and Wen MS and Chen WJ and See LC and Yeh YH}, journal={Int J Cardiol}, volume={190}, pages={20-5}}"}}, {"_id": "27710803", "pmid": 27710803, "title": "Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.", "journal": "Int J Cardiol", "authors": ["Ji MS", "Jeong MH", "Ahn YK", "Kim SH", "Kim YJ", "Chae SC", "Hong TJ", "Seong IW", "Chae JK", "Kim CJ", "Cho MC", "Rha SW", "Bae JH", "Seung KB", "Park SJ", "other Korea Acute Myocardial Infarction Registry Investigators"], "date": "2016-12-15T00:00:00Z", "doi": "10.1016/j.ijcard.2016.09.082", "meta_date_publication": "2016 Dec 15", "meta_volume": "225", "meta_issue": "", "meta_pages": "50-59", "score": 50069.12, "text_hl": "After propensity matching analysis, @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@simvastatin-ezetimibe@@@ was associated with a higher incidence of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@MACE@@@ than high-intensity statin therapy (adjusted hazard ratio: 3.090, 95% confidence interval: 1.715 to 5.566, p<0.001). ", "citations": {"NLM": "Ji MS, Jeong MH, Ahn YK, Kim SH, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Rha SW, Bae JH, Seung KB, Park SJ, other Korea Acute Myocardial Infarction Registry Investigators. Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis. Int J Cardiol. 2016 Dec 15;225():50-59. PMID: 27710803", "BibTeX": "@article{27710803, title={Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.}, author={Ji MS and Jeong MH and Ahn YK and Kim SH and Kim YJ and Chae SC and Hong TJ and Seong IW and Chae JK and Kim CJ and Cho MC and Rha SW and Bae JH and Seung KB and Park SJ and other Korea Acute Myocardial Infarction Registry Investigators}, journal={Int J Cardiol}, volume={225}, pages={50-59}}"}}, {"_id": "23288881", "pmid": 23288881, "title": "A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease.", "journal": "Diab Vasc Dis Res", "authors": ["Rosen JB", "Jimenez JG", "Pirags V", "Vides H", "Hanson ME", "Massaad R", "McPeters G", "Brudi P", "Triscari J"], "date": "2013-05-01T00:00:00Z", "doi": "10.1177/1479164112465212", "meta_date_publication": "2013 May", "meta_volume": "10", "meta_issue": "3", "meta_pages": "277-86", "score": 50068.82, "text_hl": "The low-density lipoprotein cholesterol (LDL-C) lowering efficacy of switching to @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (@<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@EZ/S@@@) 10/20 mg versus doubling the run-in statin dose (to @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg or @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ 20 mg) or switching to @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ 10 mg in subjects with @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular disease@@@ (@<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@CVD@@@) and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ was assessed. ", "citations": {"NLM": "Rosen JB, Jimenez JG, Pirags V, Vides H, Hanson ME, Massaad R, McPeters G, Brudi P, Triscari J. A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease. Diab Vasc Dis Res. 2013 May;10(3):277-86. PMID: 23288881", "BibTeX": "@article{23288881, title={A comparison of efficacy and safety of an ezetimibe/simvastatin combination compared with other intensified lipid-lowering treatment strategies in diabetic patients with symptomatic cardiovascular disease.}, author={Rosen JB and Jimenez JG and Pirags V and Vides H and Hanson ME and Massaad R and McPeters G and Brudi P and Triscari J}, journal={Diab Vasc Dis Res}, volume={10}, number={3}, pages={277-86}}"}}, {"_id": "19586799", "pmid": 19586799, "title": "At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.", "journal": "Heart Lung Circ", "authors": ["Hamilton-Craig I", "Kostner K", "Colquhoun D", "Woodhouse S"], "date": "2009-10-01T00:00:00Z", "doi": "10.1016/j.hlc.2009.02.007", "meta_date_publication": "2009 Oct", "meta_volume": "18", "meta_issue": "5", "meta_pages": "343-6", "score": 50064.04, "text_hl": "Compared with placebo, @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@CVD@@@ events were reduced by 4.4% from 20.1% to 15.7% in the @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@simvastatin/ezetimibe@@@ group (p=0.02). ", "citations": {"NLM": "Hamilton-Craig I, Kostner K, Colquhoun D, Woodhouse S. At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy. Heart Lung Circ. 2009 Oct;18(5):343-6. PMID: 19586799", "BibTeX": "@article{19586799, title={At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.}, author={Hamilton-Craig I and Kostner K and Colquhoun D and Woodhouse S}, journal={Heart Lung Circ}, volume={18}, number={5}, pages={343-6}}"}}, {"_id": "18765433", "pmid": 18765433, "title": "Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.", "journal": "N Engl J Med", "authors": ["Rossebø AB", "Pedersen TR", "Boman K", "Brudi P", "Chambers JB", "Egstrup K", "Gerdts E", "Gohlke-Bärwolf C", "Holme I", "Kesäniemi YA", "Malbecq W", "Nienaber CA", "Ray S", "Skjaerpe T", "Wachtell K", "Willenheimer R", "SEAS Investigators"], "date": "2008-09-25T00:00:00Z", "doi": "10.1056/NEJMoa0804602", "meta_date_publication": "2008 Sep 25", "meta_volume": "359", "meta_issue": "13", "meta_pages": "1343-56", "score": 50060.52, "text_hl": "Fewer @SPECIES_9606 @@@patients@@@ had @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@ischemic cardiovascular@@@ events in the @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@simvastatin-ezetimibe@@@ group (148 @SPECIES_9606 @@@patients@@@) than in the placebo group (187 @SPECIES_9606 @@@patients@@@) (hazard ratio, 0.78; 95% CI, 0.63 to 0.97; P=0.02), mainly because of the smaller number of @SPECIES_9606 @@@patients@@@ who underwent coronary-artery bypass grafting. ", "citations": {"NLM": "Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008 Sep 25;359(13):1343-56. PMID: 18765433", "BibTeX": "@article{18765433, title={Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.}, author={Rossebø AB and Pedersen TR and Boman K and Brudi P and Chambers JB and Egstrup K and Gerdts E and Gohlke-Bärwolf C and Holme I and Kesäniemi YA and Malbecq W and Nienaber CA and Ray S and Skjaerpe T and Wachtell K and Willenheimer R and SEAS Investigators}, journal={N Engl J Med}, volume={359}, number={13}, pages={1343-56}}"}}, {"_id": "25685360", "pmid": 25685360, "pmcid": "PMC4322313", "title": "High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy", "journal": "Open Heart", "authors": ["Blyme A", "Asferg C", "Nielsen OW", "Sehestedt T", "Kesäniemi YA", "Gohlke-Bärwolf C", "Boman K", "Willenheimer R", "Ray S", "Nienaber CA", "Rossebø A", "Wachtell K", "Olsen MH"], "date": "2015-02-04T00:00:00Z", "doi": "10.1136/openhrt-2014-000152", "meta_date_publication": "2015", "meta_volume": "2", "meta_issue": "1", "meta_pages": "e000152", "score": 50057.45, "text_hl": "Baseline hsCRP alone did not improve prediction of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@MCE@@@ or @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@ICE@@@ significantly.", "citations": {"NLM": "Blyme A, Asferg C, Nielsen OW, Sehestedt T, Kesäniemi YA, Gohlke-Bärwolf C, Boman K, Willenheimer R, Ray S, Nienaber CA, Rossebø A, Wachtell K, Olsen MH. High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy Open Heart. 2015;2(1):e000152. PMID: 25685360", "BibTeX": "@article{25685360, title={High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy}, author={Blyme A and Asferg C and Nielsen OW and Sehestedt T and Kesäniemi YA and Gohlke-Bärwolf C and Boman K and Willenheimer R and Ray S and Nienaber CA and Rossebø A and Wachtell K and Olsen MH}, journal={Open Heart}, volume={2}, number={1}, pages={e000152}}"}}, {"_id": "22147903", "pmid": 22147903, "title": "Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.", "journal": "Circulation", "authors": ["Greve AM", "Boman K", "Gohlke-Baerwolf C", "Kesäniemi YA", "Nienaber C", "Ray S", "Egstrup K", "Rossebø AB", "Devereux RB", "Køber L", "Willenheimer R", "Wachtell K"], "date": "2012-01-17T00:00:00Z", "doi": "10.1161/CIRCULATIONAHA.111.049759", "meta_date_publication": "2012 Jan 17", "meta_volume": "125", "meta_issue": "2", "meta_pages": "346-53", "score": 50051.312, "text_hl": "METHODS AND RESULTS: Data were obtained in asymptomatic @SPECIES_9606 @@@patients@@@ randomized to @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@simvastatin/ezetimibe@@@ combination versus placebo in the @<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@Simvastatin and Ezetimibe@@@ in @DISEASE_Aortic_Valve_Stenosis @DISEASE_MESH:D001024 @@@Aortic Stenosis@@@ (@DISEASE_Aortic_Valve_Stenosis @DISEASE_MESH:D001024 @@@SEAS@@@) study. ", "citations": {"NLM": "Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation. 2012 Jan 17;125(2):346-53. PMID: 22147903", "BibTeX": "@article{22147903, title={Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.}, author={Greve AM and Boman K and Gohlke-Baerwolf C and Kesäniemi YA and Nienaber C and Ray S and Egstrup K and Rossebø AB and Devereux RB and Køber L and Willenheimer R and Wachtell K}, journal={Circulation}, volume={125}, number={2}, pages={346-53}}"}}]}